These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10716705)

  • 1. Crystal structures of ligand complexes of P450eryF exhibiting homotropic cooperativity.
    Cupp-Vickery J; Anderson R; Hatziris Z
    Proc Natl Acad Sci U S A; 2000 Mar; 97(7):3050-5. PubMed ID: 10716705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole-induced conformational changes in the active site of cytochrome P450eryF.
    Cupp-Vickery JR; Garcia C; Hofacre A; McGee-Estrada K
    J Mol Biol; 2001 Aug; 311(1):101-10. PubMed ID: 11469860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotropic versus heterotopic cooperativity of cytochrome P450eryF: a substrate oxidation and spectral titration study.
    Khan KK; Liu H; Halpert JR
    Drug Metab Dispos; 2003 Apr; 31(4):356-9. PubMed ID: 12642459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed mutagenesis of cytochrome P450eryF: implications for substrate oxidation, cooperativity, and topology of the active site.
    Khan KK; He YA; He YQ; Halpert JR
    Chem Res Toxicol; 2002 Jun; 15(6):843-53. PubMed ID: 12067252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of the ferrous dioxygen complex of wild-type cytochrome P450eryF and its mutants, A245S and A245T: investigation of the proton transfer system in P450eryF.
    Nagano S; Cupp-Vickery JR; Poulos TL
    J Biol Chem; 2005 Jun; 280(23):22102-7. PubMed ID: 15824115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probe.
    Davydov DR; Botchkareva AE; Davydova NE; Halpert JR
    Biophys J; 2005 Jul; 89(1):418-32. PubMed ID: 15834000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the thermodynamics and cooperativity of ligand binding in cytochrome P450eryF.
    Muralidhara BK; Negi SS; Halpert JR
    J Am Chem Soc; 2007 Feb; 129(7):2015-24. PubMed ID: 17256854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary crystallographic analysis of an enzyme involved in erythromycin biosynthesis: cytochrome P450eryF.
    Cupp-Vickery JR; Li H; Poulos TL
    Proteins; 1994 Oct; 20(2):197-201. PubMed ID: 7846029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An electrostatically driven conformational transition is involved in the mechanisms of substrate binding and cooperativity in cytochrome P450eryF.
    Davydov DR; Botchkareva AE; Kumar S; He YQ; Halpert JR
    Biochemistry; 2004 Jun; 43(21):6475-85. PubMed ID: 15157081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of cytochrome P450eryF: substrate, inhibitors, and model compounds bound in the active site.
    Cupp-Vickery JR; Poulos TL
    Steroids; 1997 Jan; 62(1):112-6. PubMed ID: 9029724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational dynamics in cytochrome P450-substrate interactions.
    Li H; Poulos TL
    Biochimie; 1996; 78(8-9):695-9. PubMed ID: 9010597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric mechanisms in P450eryF probed with 1-pyrenebutanol, a novel fluorescent substrate.
    Davydov DR; Kumar S; Halpert JR
    Biochem Biophys Res Commun; 2002 Jun; 294(4):806-12. PubMed ID: 12061778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An A245T mutation conveys on cytochrome P450eryF the ability to oxidize alternative substrates.
    Xiang H; Tschirret-Guth RA; Ortiz De Montellano PR
    J Biol Chem; 2000 Nov; 275(46):35999-6006. PubMed ID: 10956654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-assisted catalysis in cytochrome P450eryF.
    Cupp-Vickery JR; Han O; Hutchinson CR; Poulos TL
    Nat Struct Biol; 1996 Jul; 3(7):632-7. PubMed ID: 8673608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR studies of ligand binding to P450(eryF) provides insight into the mechanism of cooperativity.
    Roberts AG; Díaz MD; Lampe JN; Shireman LM; Grinstead JS; Dabrowski MJ; Pearson JT; Bowman MK; Atkins WM; Campbell AP
    Biochemistry; 2006 Feb; 45(6):1673-84. PubMed ID: 16460014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of cytochrome P450eryF involved in erythromycin biosynthesis.
    Cupp-Vickery JR; Poulos TL
    Nat Struct Biol; 1995 Feb; 2(2):144-53. PubMed ID: 7749919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of serine-246 in cytochrome P450eryF-catalyzed hydroxylation of 6-deoxyerythronolide B.
    Kim C; Kim H; Han O
    Biosci Biotechnol Biochem; 2001 Apr; 65(4):752-7. PubMed ID: 11388449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 7-Benzyloxyquinoline oxidation by P450eryF A245T: finding of a new fluorescent substrate probe.
    Khan KK; Halpert JR
    Chem Res Toxicol; 2002 Jun; 15(6):806-14. PubMed ID: 12067248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the proton-assisted pathway to formation of the catalytically active, ferryl species of P450s by molecular dynamics studies of P450eryF.
    Harris DL; Loew GH
    J Am Chem Soc; 1996 Jul; 118(27):6377-87. PubMed ID: 11540056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3.
    Girvan HM; Seward HE; Toogood HS; Cheesman MR; Leys D; Munro AW
    J Biol Chem; 2007 Jan; 282(1):564-72. PubMed ID: 17077084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.